1. Home
  2. HOOD vs VRTX Comparison

HOOD vs VRTX Comparison

Compare HOOD & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robinhood Markets Inc.

HOOD

Robinhood Markets Inc.

HOLD

Current Price

$103.50

Market Cap

105.6B

Sector

Technology

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$477.36

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOOD
VRTX
Founded
2013
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
105.6B
115.7B
IPO Year
2021
1991

Fundamental Metrics

Financial Performance
Metric
HOOD
VRTX
Price
$103.50
$477.36
Analyst Decision
Buy
Buy
Analyst Count
24
27
Target Price
$120.14
$509.58
AVG Volume (30 Days)
20.1M
1.4M
Earning Date
02-10-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
304.26
N/A
EPS
2.39
14.22
Revenue
$4,204,000,000.00
$11,723,300,000.00
Revenue This Year
$56.12
$10.92
Revenue Next Year
$24.09
$8.56
P/E Ratio
$44.02
$33.34
Revenue Growth
74.58
10.33
52 Week Low
$29.66
$362.50
52 Week High
$153.86
$519.68

Technical Indicators

Market Signals
Indicator
HOOD
VRTX
Relative Strength Index (RSI) 34.18 61.75
Support Level $104.45 $429.00
Resistance Level $109.05 $485.00
Average True Range (ATR) 4.43 12.81
MACD -0.70 1.80
Stochastic Oscillator 2.80 85.31

Price Performance

Historical Comparison
HOOD
VRTX

About HOOD Robinhood Markets Inc.

Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: